The most promising derivatives regarding anticancer activity and selectivity were in vitro evaluated for their inhibitory activities against MMP-2, CA II, and VEGFR-2 which are crucial in various carcinogenesis events of the selected cancer types [25,28,55,56,57,58,59,60,61]. The gene discussed is MMP2; the disease is cancer.